Sign In

Eran Eden

Husband, father, entrepreneur, human being.

Eran Eden is an accomplished scientist, entrepreneur, and leader in the field of biotechnology. He has a strong educational background, having studied Biology and Computer Science at Technion-Machon Technologi Le' Israel, and a PhD in Systems Biology from Weizmann Institute of Science. Eden is also a graduate of the prestigious Leadership Program at Harvard Business School.

He co-founded and currently serves as CEO of MeMed, a biotechnology company that is developing innovative medical solutions. Prior to his leadership role at MeMed, Eden was an algorithm and software developer of biomedical data analysis applications at Agilent Technologies, a TA and lecturer at Technion - Israel Institute of Technology, and an algorithm developer for computer vision applications at ISL - Intelligent Systems Laboratory.

Eden is a former Board member of the Israeli Advanced Technology Industries (IATI) and a former member of The Health Network. He has also been a lecturer of Matlab and Data Analysis at Weizmann Institute of Science.

Overall, Eden's unique combination of educational and professional experience in computer science, biology, and business make him an expert in the field of biotechnology and an invaluable asset to any team focused on solving big medical problems.

Highlights

Jul 11 · linkedin

A unique opportunity to join our A+ team and lead regulatory and QA.

May 15 · linkedin

Another exciting development! The Apollo Study, a multi-year blinded diagnostic accuracy study conducted across top US medical centers, has further independently validated the performance of #MeMedBV.

Highlights: ✅ First study involving patients from diverse US acute care settings that includes outpatient clinics. ✅ MeMed BV achieved high performance: sensitivity of 90%, specificity of 93%, and a 99% NPV in distinguishing bacterial vs. viral infections in both children and adults. ✅ First validation of #MeMedKey platform, delivering results in just 15 minutes. ✅ Potential to more than double the reduction in unnecessary antibiotic use.

A special thank you to lead authors Richard Bachur, Shelly Kaplan, and Richard Rothman, for their pivotal insights and efforts to challenge the status quo. Many thanks also to the principal investigators and adjudicators who meticulously reviewed thousands of clinical cases. Special thanks to team MeMed for their relentless dedication.

Generating high-quality clinical evidence has been a cornerstone of our efforts to advance host-response solutions. This study marks another significant step forward.

Read full study here: https://https://lnkd.in/dSbgHYZT

#HostResponse #AMR #AntimicrobialResistance #JACEP #JournalOfTheAmericanCollegeOfEmergencyPhysicians

Related Questions

What are Eran Eden's main responsibilities at IATI?
How did Eran Eden's background in computer engineering and biology influence his career?
What are some of the notable achievements of MeMed under Eran Eden's leadership?
How has Eran Eden contributed to the Israeli tech industry?
What other organizations or companies has Eran Eden been involved with?
Eran Eden
Eran Eden, photo 1
Eran Eden, photo 2
Add to my network

Location

Haifa, Haifa District, Israel